These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28980618)

  • 1. [The use of acetyl-L-carnitine in gerontological practice].
    Ponomareva EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6. Vyp. 2):81-86. PubMed ID: 28980618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The therapeutic potential of acetyl-L-carnitine in the treatment of cognitive and depressive disorders in the elderly].
    Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(6. Vyp. 2):37-45. PubMed ID: 30346432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
    Passeri M; Cucinotta D; Bonati PA; Iannuccelli M; Parnetti L; Senin U
    Int J Clin Pharmacol Res; 1990; 10(1-2):75-9. PubMed ID: 2201659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy of combined L-carnitine and acetyl-L-carnitine on idiopathic asthenospermia].
    Cheng HJ; Chen T
    Zhonghua Nan Ke Xue; 2008 Feb; 14(2):149-51. PubMed ID: 18390180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's L-A-C got to do with it?
    Notes Undergr; 1997 Nov; (No 36):6. PubMed ID: 11365206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R
    Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The action of carnitine-series preparations in experimental alloxan diabetes mellitus].
    Kim EK; Trevisani C; Trevisani M
    Eksp Klin Farmakol; 1992; 55(4):35-6. PubMed ID: 1458184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological changes in demented patients treated with acetyl-L-carnitine.
    Sinforiani E; Iannuccelli M; Mauri M; Costa A; Merlo P; Bono G; Nappi G
    Int J Clin Pharmacol Res; 1990; 10(1-2):69-74. PubMed ID: 2387665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
    Cipolli C; Chiari G
    Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacodynamics of acetyl-L-carnitine in patients with Parkinson's disease.
    Puca FM; Genco S; Specchio LM; Brancasi B; D'Ursi R; Prudenzano A; Miccoli A; Scarcia R; Martino R; Savarese M
    Int J Clin Pharmacol Res; 1990; 10(1-2):139-43. PubMed ID: 2387661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats.
    Ferreira MR; Camberos Mdel C; Selenscig D; Martucci LC; Chicco A; Lombardo YB; Cresto JC
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):205-11. PubMed ID: 23278446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study.
    Hagen K; Brenner E; Linde M; Gravdahl GB; Tronvik EA; Engstrøm M; Sonnewald U; Helde G; Stovner LJ; Sand T
    Cephalalgia; 2015 Oct; 35(11):987-95. PubMed ID: 25601916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
    Goety CG; Tanner CM; Cohen JA; Thelen JA; Carroll VS; Klawans HL; Fariello RG
    Mov Disord; 1990; 5(3):263-5. PubMed ID: 2143808
    [No Abstract]   [Full Text] [Related]  

  • 14. Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion.
    Calvani M; Arrigoni-Martelli E
    Int J Tissue React; 1999; 21(1):1-6. PubMed ID: 10463134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitamine-like substances L-carnitine and acetyl-L-carnitine: from biochemical studies to medicine].
    Kopelevich VM
    Ukr Biokhim Zh (1999); 2005; 77(4):30-50. PubMed ID: 16568602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acetyl-L-carnitine on ethanol consumption and alcohol abstinence syndrome in rats.
    Mangano NG; Clementi G; Costantino G; Calvani M; Matera M
    Drugs Exp Clin Res; 2000; 26(1):7-12. PubMed ID: 10761531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.
    Sima AA; Ristic H; Merry A; Kamijo M; Lattimer SA; Stevens MJ; Greene DA
    J Clin Invest; 1996 Apr; 97(8):1900-7. PubMed ID: 8621774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral blood flow in patients with chronic cerebrovascular disease: effect of acetyl L-carnitine.
    Postiglione A; Cicerano U; Soricelli A; De Chiara S; Gallotta G; Salvatore M; Mancini M
    Int J Clin Pharmacol Res; 1990; 10(1-2):129-32. PubMed ID: 2387659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effect of acetyl-L-carnitine and/or nifedipine against selenite-induced cataractogenesis in young albino rats.
    Farghaly LM; Ghobashy WA; Shoukry Y; El-Azab MF
    Eur J Pharmacol; 2014 Apr; 729():1-9. PubMed ID: 24530554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia.
    Lenzi A; Sgrò P; Salacone P; Paoli D; Gilio B; Lombardo F; Santulli M; Agarwal A; Gandini L
    Fertil Steril; 2004 Jun; 81(6):1578-84. PubMed ID: 15193480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.